Study of cytokines in bronchoalveolar lavage fluid for patients with idiopathic pulmonary fibrosis
Dan Zhou
Abstract
Dan Zhou
Abstract
Objective: To study the changes of transforming growth factor-beta1 TGF-a1 and platelet derived growth factor (PDGF) and the transformation of cells in bronchoalveolar lavage fluid (BALF), to discuss their clinic value. Methods: The ELISA methods were used to measure the contents of TGF-a1 PDGF. Results: In the BALF of patients with IPF, the contents of TGF-a1, PDGF were significantly increased than those in normal control subjects (P0.01, P0.05). Conclusion: TGF-a1 and PDGF are involved in formation of IPF, to measure the contents of TGF-a1 PDGF could be helpful to diagnosis of IPF and act as the markers of activity of disease; to block the biologic activity of TGF-a1 PDGF may be of a great future as a treatment for IPF.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To study the changes of transforming growth factor-beta1 TGF-a1 and platelet derived growth factor (PDGF) and the transformation of cells in bronchoalveolar lavage fluid (BALF), to discuss their clinic value. Methods: The ELISA methods were used to measure the contents of TGF-a1 PDGF. Results: In the BALF of patients with IPF, the contents of TGF-a1, PDGF were significantly increased than those in normal control subjects (P0.01, P0.05). Conclusion: TGF-a1 and PDGF are involved in formation of IPF, to measure the contents of TGF-a1 PDGF could be helpful to diagnosis of IPF and act as the markers of activity of disease; to block the biologic activity of TGF-a1 PDGF may be of a great future as a treatment for IPF.
Key concepts: Bronchoalveolar lavage, Platelet-derived growth factor receptor, Medicine, Idiopathic pulmonary fibrosis, Transforming growth factor, Pulmonary fibrosis, Growth factor, Platelet-derived growth factor